Why Open Drug Discovery Needs Four Simple Rules for Licensing Data and Models

  • Antony J. Williams, John Wilbanks, Sean Ekins
  • PLoS Computational Biology, September 2012, Public Library of Science (PLoS)
  • DOI: 10.1371/journal.pcbi.1002706

Simple Rules are needed for Licensing Data and Models for Open Drug Discovery

What is it about?

Data licenses are going to become increasingly important in science in the future, especially as we see more scientists embracing open notebook science, open science, and open-access publishing, and funding bodies promoting the increased accessibility of the fruits of their funding. We propose simple rules for developing data licensing approaches inside scientific projects.

Why is it important?

We have formulated four simple rules to license data for open drug discovery represent a proposed starting point for consideration by database producers. These licenses could equally be used by individual scientists on their blogs and other online environments or accounts in which they make their data and models available for others.

Read Publication


The following have contributed to this page: Dr Antony John Williams and Dr Sean Ekins